Financial, market and economic news

Could This Healthcare SaaS Stock Be the Next Veeva Systems?

It’s no longer a secret that the software-as-a-service (SaaS) business model has huge advantages. It costs next to nothing to give a new customer access; upgrades are the norm; and wide moats form via both high switching costs and network effects.

It’s no wonder, then, that Veeva Systems (NYSE: VEEV) — a SaaS company that caters primarily to large pharmaceutical players — has seen its stock return more than 1,100% in the past five years. Could there be other healthcare SaaS stocks capable of returning such figures?

Today, we’ll examine Health Catalyst (NASDAQ: HCAT), a SaaS company that aims to partner with hospitals and other healthcare organizations to improve outcomes. As you’ll see below, while Health Catalyst has a lot going for it, Veeva might not be the best comparison. Here’s why.

Continue reading

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy